Question special

These days when the antibiotic resistance is a growing public health problem and the lack of new antibiotics threatens our capacity to care for patients with infectious diseases; we must be very careful in the selection of patients that require antibiotic treatment and avoid the use of these molecules in other kind of infections (i.e. viral or fungal infection) to prevent antimicrobial resistance. According with the findings in the EPIC study, only 14% of the isolates were bacterial pathogens (11% bacterial only and 3% bacterial-viral co-detection), Does this means that 86% of our patients with pneumonia do not require antibiotic treatment?